Cancer Diagnostics – Products

Thermo Scientific clinical LIMS delivers a lab-centric solution for patient-centric results.

Using PLA® immunoassay platform, up to 74 potential cancer biomarkers are analyzed with high sensitivity in precious biobanked plasma samples, in no more than 2 µl of sample.

UCSF researchers have identified serum microRNAs by using Fluidigm Corporation's BioMark™ System and Digital Array™ IFCs.

MDV3100 continues to show durable antitumor activity as evaluated by median times to prostate-specific antigen progression and radiographic progression.

Researchers will use the NMR instrumentation for rapid, high-throughput analyses, aiming for characterization, treatment planning and monitoring of cancer patients.

ExpressArt® mRNA Amplification Kits from AMSBIO offer an elegant technological solution for qRT-PCR and gene expression array studies.

ExpressArt® mRNA Amplification Kits from AMSBIO offer an elegant technological solution for qRT-PCR and gene expression array studies that overcomes the limitations of sample quality and quantity.

MicroRNAs are the subject of intense research focus due to the pivotal role they play in essentially all important biological processes and because of their potential to serve as cancer biomarkers and therapeutic targets.

Bioo Scientific recently launched the MiraMas™ Kit, which uses a novel approach for SYBR Green/qPCR-based profiling of microRNAs and other small RNAs.

Roche LightCycler utilized for rapid methylation detection in archival tissue samples.